Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SRX Global Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2018
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2025
FY2024
FY2025
Revenue
0
14.8
15.6
42.6
46
54.7
38.6
35
6.53
Cost of revenue
0
7.49
9.72
26.5
30.6
39.4
26.8
22
5.01
Gross profit
0
7.3
5.86
16.1
15.4
15.3
11.8
13
1.53
Research and development
0.1
0.5
0.5
0.1
0.1
Selling, general and administrative
34.5
28.5
35.4
24.4
19
12.9
Selling and marketing
4.98
10.1
7.89
General and administrative
0.53
6.06
19.8
26
Operating expenses
0.53
12.5
42.2
43.4
32.6
54
33
19
12.9
Operating income
-0.53
-5.16
-36.3
-27.3
-17.3
-38.8
-21.2
-5.97
-11.4
Interest expense
0.53
0.87
0.7
9.2
0.55
1.35
0.47
0.63
Other non-operating income
-0.59
-0.87
-148
-32
20.7
-0.55
-1.59
5.81
2.77
Pre-tax income
-1.11
-59.3
3.42
-39.3
-22.8
-0.16
-8.64
Income tax
0
0
0
0.04
-0.02
0
0.01
Income from continuing operations
-1.11
Net income
-2.95
-6.03
-184
-59.3
3.39
-39.3
-22.8
-43.1
-0.17
-45
EBITDA
-5.14
-36.2
-25.6
-15.6
-37.1
-19.5
-5.84
-11.4
EPS, basic
-258.59
-137.21
-1,464.00
-319.28
6.60
-58.93
-32.29
-1.95
-0.10
-2.13
EPS, diluted
-258.59
-137.21
-1,464.00
-319.28
6.16
-58.93
-32.29
-1.95
-0.10
-2.13
Shares, basic (weighted)
0.01
0.04
0.13
0.19
0.45
0.67
0.71
22.1
1.62
21.1
Shares, diluted (weighted)
0.01
0.04
0.13
0.19
0.5
0.67
0.71
22.1
1.62
21.1
Balance sheet
FY2018
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2025
FY2024
FY2025
Cash and equivalents
0.2
3.95
2.36
3.93
21.7
3.17
4.46
0.11
3.07
1.31
Receivables
0.12
5.82
4.63
6.79
6.74
4.35
9.28
5.37
3.95
Inventory
0.01
1.56
6.58
4.87
5.25
10.3
6.61
3.37
3.87
2.08
Other current assets
0
0.25
0.08
4.07
2.94
1.05
0.81
0.5
0.48
0.79
Total current assets
0.21
5.89
17.6
17.6
43.9
27.5
16.2
13.6
15
8.13
Property, plant and equipment
0.07
0.42
0.25
0.37
0.38
0.23
6.03
0.14
0.09
Lease right-of-use assets
0
0.95
0.35
0.06
0.17
0.12
6.49
0.06
0.02
Goodwill
0
18.6
18.6
18.6
0
0.41
0.41
Intangible assets
0
14.6
13.1
11.6
10.1
7
Other non-current assets
0.03
1.33
1.36
0.12
0.54
0.16
0.21
0.19
0.17
Total assets
0.21
5.99
53.5
51.3
74.7
38.7
16.7
33.8
15.8
8.4
Accounts payable
0.04
0.77
4.05
3.14
4.55
2.93
6.93
39.8
3.14
2.15
Accrued liabilities
0.02
0.09
4.72
3.4
1.88
2.6
2.09
1.86
0.2
1.38
Deferred revenue
0.07
0.31
0.35
0.23
0.34
0.01
0.03
0.5
Short-term debt
1.03
0
20.9
8.02
0.86
0
4.62
31.6
2.41
Total current liabilities
2.86
9.03
33
54.6
7.34
5.58
13.7
81.3
7.15
3.54
Long-term debt
0
0
16.4
24.6
9.42
11.4
0.7
2.41
0
Lease liabilities
0
0.64
0.18
0.01
0.12
0.07
5.62
0.01
Total liabilities
2.86
9.03
50
79.4
16.8
17.1
13.8
88.9
7.15
8
Total debt
1.03
6.2
37.3
32.6
10.3
11.4
4.62
32.3
2.41
0
Paid-in capital
3.41
13.6
194
233
317
320
324
12.5
330
23.3
Retained earnings
6.06
-16.7
-201
-261
-259
-299
-321
-70
-322
-22.9
Other comprehensive income
2.4
Shareholders' equity
-2.65
-3.04
-7.07
-28.1
57.9
21.5
2.95
-55.1
-63.7
0.41
Total equity
-2.65
-3.04
-7.07
-28.1
57.9
21.5
2.95
-55.1
-63.7
0.41
Total liabilities and equity
0.21
5.99
53.5
51.3
74.7
38.7
16.7
33.8
15.8
8.4
Shares outstanding
0.01
0.04
0.18
0.2
0.66
0.67
0.73
22.5
1.83
0.42
Cash flow statement
FY2018
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2025
FY2024
FY2025
Net income
-2.95
-6.03
-184
-59.3
3.39
-39.3
-22.8
-43.1
-0.17
-8.64
Depreciation and amortization
0.01
0.17
1.75
1.66
1.69
1.68
4.39
0.13
0.03
Stock-based compensation
0.43
10.3
8.94
4.14
2.97
1.77
3.67
0.83
3.21
Deferred income tax
0
0
0
-0
-0.95
0.01
Change in receivables
0
-0.2
-0.1
1.19
-2.14
-0.07
2.39
-0.41
-1.15
5.41
Change in inventory
0.01
-0.4
0.23
1.45
-0.64
-6.82
3.65
2.56
2.74
0.5
Change in payables
-0.23
0.06
-1.7
-2.45
0.77
-0.76
4
10.4
-1.16
-5.99
Cash from operations
-0.84
-6.9
-21
-7.51
-11.9
-20.6
0.1
-1.48
-4.36
-8.14
Capital expenditures
-0.03
-0.11
-0.15
-0.35
-0.2
-0.02
-0.04
Acquisitions
0
-20.5
0
Cash from investing
0
-0.03
-20.2
-0.15
-0.35
-0.2
-0.02
-1.09
-2.25
5.91
Debt issued
2.35
0
Stock issued
4.67
15.8
18.1
0.92
Share buybacks
0
0
-1.6
0
-0.21
-0.14
Cash from financing
1
10.7
39.8
9.11
37.2
1.28
-5.1
0.93
5.22
12.2
Net change in cash
0.16
3.79
-1.41
1.46
25
-19.5
-5.02
-1.64
-1.39
1.41
Free cash flow
-6.93
-21.1
-7.66
-12.2
-20.8
0.08
-4.4
Interest paid
0
0.27
2.31
0.36
0.44
0.54
2.66
0.25
0.33
Income taxes paid
0
0
0
0.01
0.01
0.01
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.70 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
35.0%
Gross profit / revenue.
Operating margin
-86.0%
Operating income / revenue.
EBITDA margin
-106.6%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-155.0%
Pre-tax income / revenue.
Net margin
-258.4%
Net income / revenue.
Return on equity (ROE)
-24.4%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-24.0%
Net income / average total assets.
Return on invested capital (ROIC)
-8.5%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue
121.0%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
15.8%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
-20.6%
Depreciation and amortization / revenue.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
27.6x
Current assets / current liabilities.
Quick ratio
19.6x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
18.0x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.00x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
0.0%
Total debt / total assets.
Liabilities / assets
1.6%
Total liabilities / total assets.
Net debt
-$42.7M
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$3.05
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$1.18
Revenue / diluted weighted shares.
Book value per share
$7.33
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
2.55x
Market cap / revenue.
P/B
0.24x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
0.55x
Market cap / tangible book value, when positive.
Earnings yield
-101.2%
Net income / market cap (the inverse of P/E).
What was SRX Global Inc.'s revenue in fiscal 2025?
SRX Global Inc. reported revenue of $6.5M for fiscal 2025, 81.3% lower than the year before.
Was SRX Global Inc. profitable in fiscal 2025?
No. It reported a net loss of $45.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.